MAIA Biotechnology Inc (AMEX: MAIA) started the day on Thursday, with a price increase of 4.09% at $1.78, before settling in for the price of $1.71 at the close. Taking a more long-term approach, MAIA posted a 52-week range of $1.40-$4.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -11.40% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -11.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 51.52%. This publicly-traded company’s shares outstanding now amounts to $29.59 million, simultaneously with a float of $21.93 million. The organization now has a market capitalization sitting at $53.95 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8112, while the 200-day Moving Average is $2.0150.
MAIA Biotechnology Inc (MAIA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. MAIA Biotechnology Inc’s current insider ownership accounts for 27.63%, in contrast to 4.09% institutional ownership. According to the most recent insider trade that took place on Jun 03 ’25, this organization’s Director bought 33,333 shares at the rate of 1.50, making the entire transaction reach 50,000 in total value, affecting insider ownership by 1,305,059. Preceding that transaction, on May 08 ’25, Company’s Director bought 20,000 for 1.50, making the whole transaction’s value amount to 30,000. This particular insider is now the holder of 588,218 in total.
MAIA Biotechnology Inc (MAIA) Earnings and Revenue Records
MAIA Biotechnology Inc’s EPS increase for this current 12-month fiscal period is 51.52% and is forecasted to reach -0.69 in the upcoming year.
MAIA Biotechnology Inc (AMEX: MAIA) Trading Performance Indicators
Let’s observe the current performance indicators for MAIA Biotechnology Inc (MAIA). It’s Quick Ratio in the last reported quarter now stands at 2.35.
In the same vein, MAIA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.81, a figure that is expected to reach -0.24 in the next quarter, and analysts are predicting that it will be -0.69 at the market close of one year from today.
Technical Analysis of MAIA Biotechnology Inc (MAIA)
If we take a close look at the recent performances of MAIA Biotechnology Inc (AMEX: MAIA), its last 5-days Average volume was 0.5 million that shows progress from its year to date volume of 0.32 million. During the previous 9 days, stock’s Stochastic %D was recorded 10.39% While, its Average True Range was 47.45%.
Raw Stochastic average of MAIA Biotechnology Inc (MAIA) in the period of the previous 100 days is set at 28.36%, which indicates a major rise in contrast to 20.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1137 that was lower than 0.1464 volatility it exhibited in the past 100-days period.
